Skip to content

Net Income at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
$6.8M-90.0%
Opko Health logo
Opko HealthOPK
-$54.85M+18.9%
Merck & Co. logo
Merck & Co.MRK
-$4.24B-183%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$50M-144%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$8.64M+59.8%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$74.11M-33.9%

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Reported directly by SIGA Technologies in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's net income?
SIGA Technologies (SIGA) reported net income of -$3.45M in Q1 2026.
How has SIGA Technologies's net income changed year-over-year?
SIGA Technologies's net income decreased by 746.2% year-over-year, from -$408.22K to -$3.45M.
What is the long-term trend for SIGA Technologies's net income?
Over 3 years (2021 to 2024), SIGA Technologies's net income has grown at a -5.2% compound annual growth rate (CAGR), from $69.45M to $59.21M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.